Case selection and restrictions recommended to patients with hyperthyroidism in South America

Thyroid

Volumn 7, Issue 2, 1997, Pages 225-228

  Romaldini, João Hamilton ^a,b  

^a PONTIFÍCIA UNIVERSIDADE CATÓLICA DE CAMPINAS   (Brazil)

^b INSTITUTO DE ASSISTÊNCIA MÉDICA AO SERVIDOR PÚBLICO ESTADUAL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; RADIOACTIVE IODINE;

ARTICLE; GRAVES DISEASE; HUMAN; HYPERPARATHYROIDISM; MEDICAL DECISION MAKING; NORMAL HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; SOUTH AMERICA; TREATMENT PLANNING;

EID: 0030933758     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.225     Document Type: Article

References (12)

1. Hedley AJ, Lazarus JH, McGhee SM, Jones RB, Sharp PF, Naven LM, Beardwell CG, Hall R 1992 Treatment of hyperthyroidism by radioactive iodine. J Royal Coll Phys London 26:348-351.
2. Werner RS, Romaldini JH, Farah CS, Werner MC, Bromberg N 1991 Serum thyroid stimulating antibody, thyroglobulin levels, and thyroid suppressibility measurement as predictors of the outcome of combined methimazole and triiodothyronine therapy in Graves' disease. Thyroid 1:293-299.
3. Werner MC, Romaldini JH, Bromberg N, Werner RS, Farah CS 1989 Adverse effects related to thionamide drugs and their dose regimen. Am J Med Sci 297:216-220.
4. Franklyn JA 1994 The management of hyperthyroidism. N Engl J Med 330:1731-1738.
5. Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, Nagayama Y, Izumi M 1991 Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid 1:129-135.
6. Maciel RMB, Furlanetto RP, Werner RS, Romaldini JH 1991 The treatment of hyperthyroidism due to Graves' disease in Brazil. Comparison with European, Japanese and North American surveys. V Latin-American Thyroid Congress, Sao Paulo. 85 (abstract 1)
7. Degrossi O, Schurman LA, Argento RF 1989 Encuesta sobre el tratamento de la enfermedad de Graves. Federación Argentina de Sociedades de Endocrinologia (Suppl).
8. Di Nino FB, Esteves RZ, Furlanetto RP, Hidal JT, Matsumura LK, Maciel RMB 1996 Tratamento do hipertiroidismo por doença de Basedow Graves com iodo radioativo: Analise retrospectiva de 116 casos. II COPEM, Sao Paulo. Arq Bras Endocrinol Metab 40(Suppl 1):55 (abstract).
9. Aguayo J, Atria A, Pineda G 1987 Aims for the use of 131-I in the treatment of thyrotoxicosis: Analysis of two series treated with different doses. Rev Med Chile 931-941.
10. Reiners C 1991 Radioiodine treatment of Basedow's disease: Interference and influence factors, risk estimation. Exp Clin Endocrinol 97:275-285.
11. Ward LS, Castelo Filho A, Menabo E, Ribeiro SRR, Lima MC, Maciel RMB 1986 Estudo da relação custo/efetividade no tratamento da doença de Basedow Graves. Rev Ass Med Brasil 32:147-154.
12. Dunn JT 1996 Seven deadly sins in confronting endemic iodine deficiency, and how to avoid them. J Clin Endocrinol Metab 81:1332-1335.